Lv6
2410 积分 2024-09-23 加入
[China lymphoma diagnosis and treatment guideline (2026 edition)]
23天前
已完结
Diffuse Large B-Cell Lymphoma
23天前
已完结
One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma
1个月前
已完结
An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II
1个月前
已完结
An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II
1个月前
已完结
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial
1个月前
已完结
Surrogate end points in oncology: aligning drug development incentives and patient needs
1个月前
已关闭
Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in drug development
1个月前
已完结
A Systematic Review of the Progression of Cutaneous Lupus to Systemic Lupus Erythematosus
1个月前
已完结
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
